Association of cognitive function with albuminuria and eGFR in the general population. (scientific article)

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Q29614889

Pharmacy data in epidemiological studies: an easy to obtain and reliable tool

Q30725312

Invited commentary: Albuminuria and microvascular disease of the brain--a shared pathophysiology

Q33741444

A prospective study of albuminuria and cognitive function in older adults: the Rancho Bernardo study

Q33741459

Reference data for the Ruff Figural Fluency Test stratified by age and educational level

Q33828539

Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease

Q34570703

The importance of microalbuminuria as a cardiovascular risk indicator: A review.

Q34658359

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

Q34660044

Kidney function and cognitive performance and decline in older men.

Q35025811

Low-grade albuminuria and cardiovascular risk : what is the evidence?

Q36799139

Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships

Q36857484

Predictors of cognitive decline in older individuals with diabetes

Q36945266

Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study

Q36994171

Albuminuria and dementia in the elderly: a community study

Q37023932

Chronic kidney disease, creatinine and cognitive functioning

Q37306335

Kidney function is associated with the rate of cognitive decline in the elderly.

Q37368380

Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders

Q37451258

Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity

Q39571547

Verbal and design fluency in patients with frontal lobe lesions

Q44297956

Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III).

Q44468127

Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study

Q44948991

Figural fluency: differential impairment in patients with left versus right frontal lobe lesions.

Q45989784

Arterial stiffness and cognition in elderly persons with impaired glucose tolerance and microalbuminuria.

Q46327115

Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality

Q46384726

Cognitive impairment in chronic kidney disease

Q46471613

Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study

Q46512603

Microalbuminuria is a negative correlate for cognitive function in older adults with peripheral arterial disease: results from the U.S. National Health and Nutrition Examination Survey 1999-2002.

Q46941040

High prevalence of leukoaraiosis in cerebral magnetic resonance images of patients on peritoneal dialysis

Q48126587

The brain and the kidney connection: A model of accelerated vascular cognitive impairment

Q48481040

Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD.

Q48677154

Kidney function is related to cerebral small vessel disease.

Q51899375

Practice effects on commonly used measures of executive function across twelve months

Q73569215

P433

issue

P304

page(s)

1400-1409

P577

publication date

2011-05-12

P1433

published in

Clinical Journal of the American Society of Nephrology

Q15757929

P1476

title

Association of cognitive function with albuminuria and eGFR in the general population

P478

volume

Reverse relations

cites work (P2860)

Q34501344	A disease modification effect of APOE E4 on the association between urinary albumin excretion and cognition in Korean adults.
Q33597949	Aging and chronic kidney disease: the impact on physical function and cognition
Q37280867	Albuminuria and cognitive decline in people with diabetes and normal renal function
Q38984127	Albuminuria in Association with Cognitive Function and Dementia: A Systematic Review and Meta-Analysis.
Q34996879	Cerebral structural changes in diabetic kidney disease: African American-Diabetes Heart Study MIND.
Q34736194	Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America
Q38793810	Cognitive Impairment and Dementia in Older Adults With Chronic Kidney Disease: A Review
Q37038555	Cognitive Impairment and Progression of CKD.
Q92658895	Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study
Q48052265	Differential associations between systemic markers of disease and white matter tissue health in middle-aged and older adults
Q35214167	Duration of chronic kidney disease reduces attention and executive function in pediatric patients
Q34299678	Effect of renal impairment on cognitive function during a 3-year follow up in elderly patients with type 2 diabetes: Association with microinflammation
Q47242001	Estimated Glomerular Filtration Rate is not Associated with Alzheimer's Disease in a Northern Ireland Cohort
Q88800240	First stages chronic kidney disease have mild effects on cognitive performance. Results of a 15,105 brazilian adult baseline cohort
Q34482975	Identifying genetic variants for heart rate variability in the acetylcholine pathway
Q64055587	Low-grade impairments in cognitive and kidney function in a healthy middle-aged general population: a cross-sectional study
Q90814806	Mechanisms of cognitive dysfunction in CKD
Q50615314	Mild chronic kidney disease is associated with cognitive function in patients presenting at a memory clinic.
Q34789487	Neuronal activation in the central nervous system of rats in the initial stage of chronic kidney disease-modulatory effects of losartan and moxonidine.
Q34048920	Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals
Q50633182	Relationship between glycemic control, microalbuminuria and cognitive functions in elderly type 2 diabetic patients
Q36493190	Relationship between longitudinal measures of renal function and onset of dementia in a community cohort of older adults
Q34776124	Statin use and cognitive function: population-based observational study with long-term follow-up
Q34345278	Subclinical albuminuria is linked to gray matter atrophy in type 2 diabetes mellitus
Q45326481	The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection
Q35075501	The interaction of age and type 2 diabetes on executive function and memory in persons aged 35 years or older
Q35790467	Validity of (Ultra-)Short Recordings for Heart Rate Variability Measurements